1 / 11

Nitroimidazoles : Metronidazole and Tinidazole

Nitroimidazoles : Metronidazole and Tinidazole. Mark S. Johnson, Pharm.D ., BCPS Associate Professor and Director of Postgraduate Education. Metronidazole (Flagyl ®) . Nitroimidazole class Antiparasitic and antibacterial activity MOA

wright
Download Presentation

Nitroimidazoles : Metronidazole and Tinidazole

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nitroimidazoles:Metronidazole and Tinidazole Mark S. Johnson, Pharm.D., BCPS Associate Professor and Director of Postgraduate Education

  2. Metronidazole (Flagyl®) • Nitroimidazole class • Antiparasitic and antibacterial activity • MOA • Diffuses into organism by passive diffusion then interacts with DNA to cause loss of helical DNA structure and strand breakage, which results in inhibition of protein synthesis and cell death • Needs to be reduced for it’s action • Bactericidal

  3. Metronidazole dailymed.nlm.nih.gov

  4. Metronidazole (Flagyl®)Spectrum of Activity • Good • Anaerobes: gram positive and gram negative • Bacteroides, Fusobacterium, Clostridium, Prevotella • Protozoa: • Trichomonas, Entamoeba, Giardia • Moderate • Helicobacter pylori • Poor • Peptostreptococcus, Actinomyces, Propionibacterium

  5. Metronidazole (Flagyl®)PKS • Absorption • BA 100% • Distribution • Saliva, bile, seminal fluid, bone, liver, liver abcesses, lung, vagina, crosses BBB • Protein binding 20% • Metabolism • Hepatic (30-60%) • t1/2 of 6-8h (prolonged in hepatic and ESRD) • Excretion • Urine (60-80% as unchanged drug) • Feces (6-15%)

  6. Metronidazole (Flagyl®)ADR’s • GI: • Common: nausea, vomiting, diarrhea, metallic taste • Rarely hepatitis, pancreatitis • Neurologic • Dose-related peripheral neuropathy • Can also be optic or autonomic neuropathy • Headache • Rarely confusion, seizures • Skin—urticaria • Dark Urine • Pregnancy (category B, avoid in 1st trimester)

  7. Metronidazole (Flagyl®)Drug Interactions • Inhibits 2C9 (weak), 3A4 (moderate) • Disulfiram-like reaction when given with alcohol (inhibition of aldehydedehydrogenase) • Warfarin—increased INR • Phenytoin, phenobarbital can decrease metronidazole levels

  8. Metronidazole (Flagyl®)Clinical Uses • Anaerobic infections in general, including intra-abdominal infections • Trichomoniaisis • Bacterial vaginosis, vaginitis • GI infections caused by protozoa (amebiasis, giardiasis, others) • Pseudomembranous colitis (Clostridium difficile) • Helicobacter pylori infections

  9. Metronidazole (Flagyl®)Dosage Forms • IV: • 500mg (7.5mg/kg) Q6h-8h • possibly 15mg/kg Q12h • Not to exceed 4gm/d • Oral • Regular Release: 250mg-500mg PO Q8-12h (depending on indication) • Extended Release: 750mg QD • Topical (acne rosacea): 0.75% or 1%

  10. Tinidazole (Tindamax™) • Structurally similar to metronidazole – 2nd-generation nitroimidazole • Antiprotozoal • Mechanism: similar to metronidazole • Indications • Intestinal amebiasis and amebic liver absess– Entamoebahistolytica • Giardiasis– Giardialamblia • Trichomoniasis– Trichomonasvaginalis • Bacterial vaginosiscaused by Bacteroidesspp, Gardnerellavaginalis, Prevotella

  11. Tinidazole (Tindamax™) • t1/2: 13h (once daily dosing) • Similar ADR’s to metronidazole • Substrate for 3A4 • Availability: • 250mg and 500mg tabs • 2gm once daily with food • More expensive

More Related